OWL Oncology Research

OWL Oncology Research is a leading functional service provider dedicated to resourcing expert oncology and rare disease teams for the pharma-biotech industry. With a commitment to excellence, OWL Oncology Research ensures that clinical trials are conducted with the highest quality and efficiency, accelerating the availability of new and promising treatments to those in need.

Located primarily in Portland, OR, with additional locations in Kansas City, Missouri; New Orleans, Louisiana; London, GB; and Fort Collins, CO, OWL Oncology Research specializes in providing focused attention and experienced teams to oncology therapeutics, ensuring they receive the respect and resources they deserve. OWL Oncology Research offers a comprehensive suite of services, including site selection and qualification, site monitoring and management across all phases (I-IV), pharmacovigilance and safety, regulatory startup and maintenance, GCP/GLP vendor audits, clinical supplies reconciliation, quality assurance, and GCP site audits, as well as rescue projects.

OWL Oncology Research stands as a pillar of support for biotechnology companies, facilitating their development needs with precision and care. At OWL Oncology Research, the focus remains steadfast: to deliver exceptional clinical trial services that drive advancements in oncology and rare disease treatments. We invite the manager of OWL Oncology Research to create a customized and exclusive company showcase and product listing on our platform to further highlight your exceptional services.